GERON CORP — Director's Dealing 2024

Jun 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2024-06-06

Reporting Person: Feller Faye (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-06	Employee Stock Option (right to buy)	$1.06	A	50000	Acquired	2032-02-15	Common Stock (50000)	Direct
2024-06-06	Employee Stock Option (right to buy)	$1.93	A	200000	Acquired	2032-07-07	Common Stock (200000)	Direct

Footnotes

F1: Performance-based stock option granted on February 16, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.

F2: Performance-based stock option granted on July 9, 2022 and vested in full on June 6, 2024 upon approval by the US FDA for imetelstat in lower risk MDS.